Without knowing anything about how the process works, I would hazard a guess that one of the reasons could be that trial subjects would need to fall under specific categories such as stage of cancer and as it is an evolving disease, all medication would need to be ready for immediate use- any hiccups in the delivery that delay commencement might skew the results if the condition of a recruit changes during that period.
Ann: PharmAust receives ethics approval to begin Phase II Trial, page-8
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $129.6K | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 119947 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 119150 | 7 |
View Market Depth
| Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |